Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1273 to 1274 of 1274 entries
Sorted by: Best Match Show Resources per page
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.

The International journal on drug policy

Farrell M, Shahbazi J, Byrne M, Grebely J, Lintzeris N, Chambers M, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Nicholas T, Weiss R, Rodgers C, Cook J, Degenhardt L.
PMID: 34736130
Int J Drug Policy. 2021 Nov 01;100:103492. doi: 10.1016/j.drugpo.2021.103492. Epub 2021 Nov 01.

BACKGROUND: Opioid agonist treatment (OAT) is an effective intervention for opioid dependence. Extended-release buprenorphine injections (BUP-XR) may have additional potential benefits over sublingual buprenorphine. This single-arm trial evaluated outcomes among people receiving 48 weeks of BUP-XR in diverse community...

Preparing postbaccalaureates for entry and success in biomedical PhD programs.

Hall JD, Harrell JR, Cohen KW, Miller VL, Phelps PV, Cook JG.
UIID-AD: 3658
2016; doi: 10.1187/cbe.16-01-0054.

Certain racial and ethnic groups, individuals with disabilities, and those from low socioeconomic backgrounds remain underrepresented (UR) in the biomedical sciences. This underrepresentation becomes more extreme at each higher education stage. To support UR scholars during the critical transition...

Showing 1273 to 1274 of 1274 entries